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Abstract: Ebola virus (EBOV) causes viral hemorrhagic fever in humans and can have 
clinical fatality rates of ~60%. The EBOV genome consists of negative sense RNA that 
encodes seven proteins including viral protein 40 (VP40). VP40 is the major Ebola virus 
matrix protein and regulates assembly and egress of infectious Ebola virus particles. It is 
well established that VP40 assembles on the inner leaflet of the plasma membrane of 
human cells to regulate viral budding where VP40 can produce virus like particles (VLPs) 
without other Ebola virus proteins present. The mechanistic details, however, of VP40 
lipid-interactions and protein-protein interactions that are important for viral release remain 
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to be elucidated. Here, we mutated a loop region in the N-terminal domain of VP40 
(Lys127, Thr129, and Asn130) and find that mutations (K127A, T129A, and N130A) in this 
loop region reduce plasma membrane localization of VP40. Additionally, using total 
internal reflection fluorescence microscopy and number and brightness analysis we 
demonstrate these mutations greatly reduce VP40 oligomerization. Lastly, VLP assays 
demonstrate these mutations significantly reduce VLP release from cells. Taken together, 
these studies identify an important loop region in VP40 that may be essential to viral egress. 
Keywords: Ebola virus; filovirus; number and brightness analysis; plasma membrane; 
viral budding; VP40 
 
1. Introduction 
Ebola virus (EBOV) [1] and Marburg virus (MARV) [2] are viruses from the Filoviridae family, 
which are some of the most virulent pathogens that infect humans. These infections cause severe 
hemorrhagic fevers with fatality rates of ~60% and, to date, there have been no vaccines or therapeutic 
treatments approved by the The Food and Drug Administration (FDA). EBOV is filamentous in shape 
and the genome consists of single stranded negative sense RNA encoding seven proteins. The 
glycoprotein (GP) is exposed on the surface of the viral envelope and is responsible for entry of the 
virions [3] through an interaction with Niemann-Pick C1 receptor in the host cell [4,5]. The matrix 
protein viral protein 40 (VP40), which associates with the viral lipid coat, is important for EBOV 
budding as well as virus structure and stability [6,7]. The nucleocapsid (NC), made of nucleoprotein 
(NP), VP24, VP30, VP35 and L protein, is crucial for viral transcription and replication [8]. In the 
absence of VP40, the NC is inefficiently transported to the plasma membrane (PM) and virus particles 
do not form [9]. 
VP40, in the absence of the other six EBOV proteins, has been shown to harbor the ability to form 
virus like particles (VLPs) when expressed in human cells [10]. The VLPs that are released in response 
to VP40 expression resemble authentic Ebola virions [6,7,11,12]. Thus, VP40 has been used to study 
protein-protein and lipid-protein interactions as it serves as a representative model of budding and  
can be used in laboratory environments without BSL-4 facilities. VP40 harbors a N-terminal domain 
(NTD) that regulates dimerization [13] and a C-terminal domain (CTD) that has been shown to  
mediate membrane binding [7,13–18] and oligomerization [13] (See Figure 1). Inhibition of VP40 
oligomerization is an effective means of halting budding. Elucidation of VP40’s role in the VLP 
assembly and release is essential to identifying sites that may be targeted to inhibit the replication and 
spread of the virus [19]. Interactions of VP40 with microtubules [20], actin [21,22], and IQGAP1 [23] 
have been observed and in the case of actin may guide VP40 movement and assembly [21]. 
Additionally, VP40 has been shown to interact with the COPII protein Sec24C [24], as well as 
Tsg101 [25], which is part of the ESCRT-I complex. 
Specific lipid interactions are not yet known, but phosphatidylserine, an anionic lipid enriched in 
the PM inner leaflet, is important for C-terminal domain membrane interactions [14,15,17,18]. 
Specifically, a cationic patch in the C-terminal domain is thought to mediate association with anionic 
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membranes [13] while a hydrophobic loop mediates penetration of the domain into the hydrocarbon 
core of the bilayer [14,17]. VP40 has also been shown to play an important role in viral transcription 
through formation of a RNA binding octameric ring [13,26], but the octameric ring has not been 
observed in infectious virions or VLPs. While a number of regions of VP40 that are key determinants 
of trafficking or release have been identified, much less mechanistic information is available on the 
molecular basis of VP40 interactions with human proteins or cellular membrane lipids. 
 
 
Figure 1. VP40 harbors a N-terminal and C-terminal domain. (A) VP40 (PDB ID: 4LDB) 
is a dimer mediated by a N-terminal domain (NTD) interface. The C-terminal domain 
(CTD) mediates membrane binding through a cationic patch and also creates an interface 
for VP40 oligomerization [13]. The NTD is shown in light gray and the CTD in dark gray. 
Residues found to be important in this study (Lys127, Thr129, and Asn130) for VP40 PM 
localization, oligomerization, and budding are shown in magenta. (B) VP40 sequence 
alignment from ebolaviruses and Marburg virus for the N-terminal loop region studied 
herein. Residues found to reduce PM localization, oligomerization, and VLP formation for 
EBOV VP40 are shown in bold. 
In this study we generated several mutations of the VP40 N-terminal domain to investigate regions 
of VP40 that may be essential to VLP formation. Using a combination of cellular imaging, number and 
brightness analysis (N&B), and VLP release assays we find that a loop region in the N-terminal 
domain is important for VP40 PM localization, VP40 oligomerization, and VLP release. In contrast, 
mutations of cationic residues in the N-terminal domain outside of this loop region (K86A or K90A) 
did not appreciably alter PM localization of VP40 or VLP release. Thus, this N-terminal domain loop 
region may play an important role in VP40-protein or VP40-membrane interactions with the host cell. 
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2. Experimental Section 
2.1. Materials 
Restriction endonucleases and enzymes for molecular biology were obtained from New England 
Biolabs (Beverly, MA, USA). The QuikChange site-directed mutagenesis kit was from Agilent 
Technologies, Santa Clara, CA, USA. Nunc Lab-Tek I Chambered Cover Glasses 8-well and 
bicinchoninic acid (BCA) protein assay kit were from Thermo Fisher Scientific (Waltham, MA, USA). 
Lipofectamine 2000 and Lipofectamine LTX were from Invitrogen (Carlsbad, CA, USA). 
2.2. Molecular Biology and Protein Expression 
VP40 mutants were generated in pcDNA3.1 using a QuikChange site-directed mutagenesis kit and 
then subcloned into the pGEX-4T-1 vector using the EcoRI and XhoI restriction sites. The introduced 
mutations were confirmed by automated DNA sequencing using the primer 5’ CCG GAA TTC GCC 
ATG AGG CGG GTT ATA 3’. VP40 and respective mutations were purified to homogeneity as 
previously described [14,17]. Circular dichroism of WT VP40 and mutations was performed as 
previously described [17]. 
2.3. Cell Imaging 
HEK293 cells were cultured and maintained at 37 °C in a 5% CO2 humidified incubator 
supplemented with DMEM (low glucose) containing 10% FBS and 1% Pen/Strep. After trypsinization, 
cells were transferred from a T-25 tissue culture flask to an 8-well plate used for imaging. Cells were 
then grown to 50%–80% confluency and transfected with 1 µg DNA/dish using lipofectamine 2000 
according to the manufacturer’s protocol. CHO-K1 cells were cultured and maintained at 37 °C in a 
5% CO2 humidified incubator supplemented with DMEM/F12 (low glucose) containing 10% FBS and 
1% Pen/Strep. After trypsinization, cells were transferred from a T-25 tissue culture flask to an 8-well 
plate used for imaging. Cells were then grown to 50%–80% confluency and transfected with 1 µg 
DNA/dish using lipofectamine LTX according to the manufacturer’s protocol. Cells were imaged 
using a Zeiss LSM 710 confocal microscope using a Plan Apochromat 63× 1.4 NA oil objective. The 
488 nm line of the Ar ion laser was used for excitation of EGFP. The laser power was maintained at 
1% throughout the experiment with the emission collected through a 493–556 nm filter. 
2.4. Total Internal Reflection Fluorescence Microscopy Imaging 
Total Internal Reflection Fluorescence (TIRF) microscopy imaging was performed using a 
homebuilt TIRF imaging system (model No. IX81 microscope (Olympus, Melville, NY, USA) as 
described previously [27]. For N&B analysis, 512 frames were analyzed per image series. HEK293T 
cells expressing monomeric EGFP used as a brightness standard were imaged under the same 
conditions as EGFP-VP40 and respective mutations. The brightness of the EGFP was used as the 
brightness of the monomer (Figure 4). The selection window for analysis in the brightness versus 
intensity plot was based on the average brightness of a monomer (0.104), which allowed for selection 
of oligomeric size based upon addition of each monomer to yield, dimer, trimer, etc. Thus, the 
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selection window for each species is based upon the average brightness, which will yield an average 
population of each species in the respective area of analysis. 
N&B analysis is based upon moment analysis and allows for measurement of the average number 
of molecules as well as brightness in each pixel of a fluorescent microscopy image [27]. Here, the 
average brightness of a particle is determined from the ratio (of variance to intensity) at each pixel. 
Fluctuating particles can be determined by dividing the average intensity by the brightness at each 
pixel. In live cells, intensity may be attributed to autofluorescence, scattering, bright immobile 
particles, or fast moving particles that are dim. To control for these parameters, the N&B analysis 
accounts for these limitations by calculating the total variance, which also incorporates the detector 
noise. For particles fluctuating in the focal volume, the variance is proportional to the particle 
brightness; however, the variance of the immobile particles, scattering, autofluorescence, and detector 
noise is proportional to the intensity of these components. Thus, only fluorescent fluctuations that are 
dependent upon the mobile particles (square of the brightness) have a ratio of the variance to intensity 
>1. Brightness maps then allow for pixel resolution of the clustering of fluorescently labeled proteins. 
For the electron multiplying CCD camera the following equation was used to compute the number 
and brightness. 
N = (< I > - offset)2/(σ2 − σ02) (1) 
B = (σ2 − σ02)/(< I > - offset) (2) 
where N and B are the apparent number and the brightness of the molecule, < I > is the average 
intensity, σ2 is the variance and offset and σ02 are the intensity and noise variance due to the camera. 
With these parameters properly calibrated using EGFP, we obtained the distribution of the brightness 
of each individual pixel in the image of the cell under investigation. 
2.5. VLP Assays 
To determine if VLPs were efficiently released for different mutations compared to WT, EGFP-
VP40, EGFP-VP40-K86A, EGFP-VP40-K90A, EGFP-VP40-K127A, EGFP-VP40-T129A, EGFP-VP40-
N130A or EGFP were expressed in CHO-K1 cells for 48 hours. VLPs were then isolated from cellular 
media as previously described [14,17,21]. Cell lysates and VLP samples were mixed with SDS loading 
buffer and were boiled before loading on an 8% SDS-PAGE gel. The gel was then transferred to a 
nitrocellulose membrane (Bio-Rad) that was later incubated with primary rabbit polyclonal anti-EGFP 
antibody (Thermo Scientific) (1:1000 dilutions) or rabbit polyclonal anti-GAPDH (Santa-Cruz 
Biotechnology) followed by goat anti-Rabbit HRP (Bio-Rad) conjugate as secondary antibody 
according to the manufacturers protocol (Thermo Scientific). Blots were exposed using ImageQuant 
LAS 4000 (GE Healthcare). This method allows a comparison of VP40 in VLPs versus cell lysate 
using GAPDH as a loading control. Experiments were performed in triplicate. 
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3. Results and Discussion 
3.1. VP40 Protein-Protein and Lipid-Protein Interactions 
A number of regions and amino acids in VP40 have been found to be important for VP40  
trafficking [24], PM localization [25,28,29], membrane binding [7,13,14,17], oligomerization [13], and 
protein-protein interactions. For instance, VP40 has a N-terminal region containing two overlapping 
late-domains (L-domains), PTAP and PPxY that interact with Tsg101 [25] and Nedd4 [30], 
respectively. The C-terminal domain, which has been shown to mediate the association of VP40 with 
membranes also can insert into the membrane bilayer with an exposed hydrophobic patch that favors 
membrane penetration to the inner leaflet of the PM [14,17]. Despite these discoveries little 
mechanistic information is available on the molecular basis of VP40-protein or VP40-lipid interactions 
and a number of VP40 interactions with proteins or lipids likely remain unknown. 
To further screen for regions of VP40 that are important for PM localization and viral egress we 
randomly introduced mutations into the VP40 N-terminal domain to screen for changes in PM  
localization. To this end, three mutations showed distinct changes in the initial screen and included 
K127A, T129A, and N130A, which were predominately localized to the cytoplasm of HEK293 and 
CHOK-1 cells (Figure 2). In contrast, other mutations that reduced positive charge in the N-terminal 
domain (K86A and K90A) did not show appreciable changes in PM localization in the initial screen 
and were used as controls. To determine if any major structural changes occurred for these mutations 
we performed circular dichroism (CD) spectroscopy on WT VP40 and the respective mutations. As 
shown in Figure 3, mutations and WT had overlapping spectra indicating that no major structural 
changes occurred for VP40. Thus, we decided to more intensely investigate these five mutations in the 
PM localization, oligomerization and VLP release of VP40. 
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Figure 2. Cellular localization of VP40 and mutations in HEK293 and CHOK-1 cells.  
(A) HEK293 cells were grown in an 8-well plate and transfected with WT VP40, K86A, 
K90A, K127A, T129A, and N130A DNA containing an EGFP fusion tag. Cells were 
imaged after 20 h using a Zeiss LSM 710 confocal microscope with a 63× 1.4 numerical 
aperture oil objective. Scale bar = 10 µm. (B) CHOK-1 cells were grown in an 8-well plate 
and transfected with WT VP40, K86A, K90A, K127A, T129A, and N130A DNA 
containing an EGFP fusion tag. Cells were imaged after 16 h using a Zeiss LSM 710 
confocal microscope with a 63× 1.4 numerical aperture oil objective. Scale bar = 10 µm. 
(C) A histogram was plotted to demonstrate the percentage of HEK293 cells that displayed 
detectable PM localization for WT VP40 and mutations. Experiments were repeated in 
triplicate using at least 100 cells in each experiment to determine the S.D. as shown.  
One-way ANOVA analysis was used to calculate the standard error of the mean and  
p-value. ** p < 0.001. 
 
Figure 3. Circular dichroism spectra of VP40 and mutants employed in this study. The 
spectra were taken on a JASCO 815 CD spectrometer scanned from 195–250 nm in a 1 
mm quartz spectrophotometer cell. Each measurement was performed with 5 mg of 
indicated protein and was performed in triplicate to yield the mean representative scans. 
Molar ellipticity was defined according to the JASCO software [31] and was subtracted 
from a control buffer scan. 
3.2. VP40 Cellular Localization 
The cellular localization of VP40 and respective mutations were analyzed in HEK293 and CHOK-1 
cells. To analyze the effect of the mutant’s in cells, we transfected HEK293 cells with plasmids 
encoding WT VP40, K86A, K89A, K127A, T129A and N130A, all of which harbor an N-terminal 
EGFP tag. The cells were imaged using confocal microscopy 20 h post-transfection in HEK293 cells 
and 16 h post-transfection in CHOK-1 cells. As shown in Figure 2A, WT EGFP-VP40 is 
predominantly localized to the PM with strong visual evidence of VLP extensions stemming from the 
PM. In contrast, T129A and N130A display a diffuse cytosolic localization and a significant reduction 
in PM localization (Figure 2A). K127A also significantly reduced PM localization and evidence of 
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VLP egress but to a lesser extent than T129A and N130A. For these three mutations, ~10%–20% of 
cells exhibited visually detectable PM localization (Figure 2C). Moreover, when PM localization of 
K127A, T129A, or N130A was detectable, the amount of VP40 localized to the PM was much lower 
than WT EGFP-VP40 expressing cells (see more details below). K86A and K90A displayed similar 
PM localization and formation of filamentous extensions in HEK293 cells and did not display a 
statistically significant reduction in PM localization (Figure 2C). To further quantify the PM 
localization of VP40 and respective mutations, PM intensity determination was performed using the 
Zeiss software [32] to determine the relative intensity of the EGFP signal in at least five regions of 
interest (ROI, same area of analysis) in HEK293 cells. The cytoplasmic intensity of EGFP was then 
measured in 5 distinct ROIs of the same area. These average signals were used for assessing the ratio 
of PM VP40 EGFP intensity/(total VP40 EGFP intensity (cytoplasmic + membrane)) to provide a 
quantitative estimate of PM localization. Seven different cells for each construct, which were repeated 
in triplicate on different days, were used to determine the relative PM localization of EGFP-VP40 and 
respective mutations based upon EGFP intensity. The analysis revealed the average PM intensity to be 
87% ± 6% for WT, 86% ± 5% for K86A, 82% ± 8% for K90A, 13% ± 3% for K127A, 7% ± 3% for 
T129A and 8% ± 2% for N130A, yielding similar results to the number of cells displaying PM 
localization that was determined by visual inspection (Figure 2C). 
Similarly, WT, K86A, and K90A had extensive PM localization in CHOK-1 cells (Figure 2B) while 
K127A and T129A had a significant reduction in PM localization harboring some signal on the PM 
and a small amount of filamentous protrusions extending from the PM. N130A, however, displayed 
little detectable PM localization in CHOK-1 cells. Quantification of PM localization in CHOK-1 cells 
was only performed by counting cells that had visually detectable PM localization. 
3.3. VP40 Oligomerization 
To investigate if the N-terminal domain mutations altered VP40 oligomerization in HEK293 cells 
we used TIRF microscopy and N&B analysis [14,27] to study the oligomerization state of VP40 and 
mutants at the PM. VP40 oligomerizes on the inner leaflet of the PM into hexamers and larger 
oligomers that are enriched in PM protrusion sites [14,27]. TIRF is well suited for this approach as it 
excites fluorescent molecules on or near the PM while N&B analysis allows for measurement of the 
average number of molecules as well as brightness in each pixel of a fluorescent image. Thus, this 
method is well suited to resolve the spatial distribution of VP40 and VP40 mutant oligomers in live 
cells [27]. The calibration with monomeric EGFP allows for the selection of oligomers based upon the 
brightness of the monomer. Thus, selection windows in the brightness versus intensity plots can be 
used to select the average brightness of each species of interest (monomer, dimer, hexamer, etc.) to 
visualize the cellular localization of each species. The average brightness of a monomer was 1.104 in 
the brightness versus intensity plot meaning the brightness of a dimer was 1.208 and that of a trimer 
was 1.312. Thus, we chose to analyze monomers and dimers together as gleaning the accurate 
separation in the brightness versus intensity plot (difference of 0.104 units of brightness) is difficult to 
interpret accurately. Similarly, we have chosen to analyze trimers and dimers together (difference of 
0.1 units of brightness) and molecules that are hexameric and larger together. This provides a means of 
analyzing VP40 assembly into hexamers that may concatenate into larger filaments at the PM as 
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previously reported [13,14,27]. Additionally, these larger assemblies are needed to induce PM 
structural changes and VLP egress. Specifically, we compare the formation of VP40 oligomers that are 
hexameric and larger to that of VP40 monomers and dimers. This allows for assessment of a 
statistically significant reduction in oligmerization of VP40. 
Monomeric EGFP was first expressed as a control in HEK293 cells to calibrate the instrument for 
detection of oligomerization (Figure 4) in five independent experiments. Subsequently, cells expressing 
EGFP-VP40 were imaged in seven independent experiments and as previously reported [14,27], the 
predominant form of VP40 on the PM were monomers and dimers (See Figure 5). Hexamers and 
larger oligomers (>8) were also enriched but localized almost exclusively to membrane regions 
extending from the PM (Figure 5A,E). This along with previous studies [13] implies the dimers build 
higher order oligomers that are then involved in VLP egress. Previously, the sites of protrusion were 
lost when VP40 mutants were employed that abolished oligomerization [14,17,27] strongly suggesting 
the membrane protrusion sites require VP40 membrane association and oligomerization, which is also 
supported by the recent structural observations of VP40 assembly [13]. In order to test the role of the 
N-terminal domain loop residues in VP40 oligomerization we used TIRF and N&B to assess the 
oligomerization of K127A (Figure 6) and N130A (Figure 7) in five independent experiments. Both 
mutations displayed a very low fluorescent intensity of EGFP on the PM (Figures 6 and 7) in a similar 
fashion to cellular localization experiments shown in Figure 2. K127A and N130A, which had a 
similar level of monomers and dimers as WT, also exhibited a drastic loss of brightness or oligomers 
(variance/intensity) at the PM (see Figures 5B,C,G, 6B,C, and 7B,C) as well as loss of membrane 
protrusion (VLP egress sites) sites. This suggests a lack of EGFP clustering and oligomerization for 
these mutations. Indeed, brightness versus intensity plots revealed little oligomerization for these 
mutants (Figures 5B,C, 6B,C and 7B,C) with the predominant species in these cells being dimers and 
monomers. Analysis of frequency versus apparent brightness plots, for WT and mutations oligomer to 
monomer plus dimer ratios, demonstrated a statistically significant reduction in VP40 oligomerization 
when membrane association was ablated for K127A or N130A (Figure 5G). 
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Figure 4. N&B Analysis of monomeric EGFP. (A) TIRF microscopy was used to image 
monomeric EGFP expressed in HEK293 cells; (B) Brightness versus intensity plot 
displaying monomers (red box); (C) Brightness distribution of EGFP near the PM 
displaying monomers (red) highlighted in B; (D) Frequency versus apparent brightness plot 
demonstrates a tightly correlated monomeric EGFP; (E) TIRF intensity image displaying 
monomeric EGFP distribution near the PM (blue = least intense; red = most intense); 
(F) Cellular brightness map of monomeric EGFP from the TIRF image (blue = least 
intense; red = most intense). Scale bar = 18 µm. 
 
Figure 5. N&B Analysis of monomeric WT VP40. (A) TIRF microscopy was used to 
image EGFP-VP40 expressed in HEK293 cells elucidating extensive VP40 enriched PM 
protrusions; (B) Brightness versus intensity plot displaying monomers and dimers (red 
box), trimers and tetramers (blue box), and hexamers to octamers (green box); 
(C) Brightness distribution of EGFP at or on the PM displaying monomers and dimers 
(red), trimers and tetramers (blue), and hexamers to octamers (green) highlighted in B; 
(D) Frequency versus apparent brightness plot of EGFP-VP40 demonstrates significant 
oligomerization of VP40 at or near the PM of HEK293 cells; (E) TIRF intensity image 
displaying EGFP-VP40 distribution at or near the PM (blue = least intense; red = most 
intense). VP40 oligomers are enriched in the cellular protrusions; (F) Cellular brightness 
map of EGFP-VP40 from the TIRF image demonstrates the exclusive localization of VP40 
oligomers to membrane protrusion sites (blue = least intense; red = most intense); 
Viruses 2014, 6 3847 
 
 
(G) Histogram plot of the ratio of VP40 oligomers/VP40 (monomers+dimers) to 
demonstrate the reduction of PM oligomerization of K127A and N130A is statistically 
significant. One-way ANOVA analysis was used to calculate the standard error of the 
mean and p-value. ** p < 0.001. Scale bar = 18 µm. 
 
Figure 6. N&B Analysis of K127A. (A) TIRF microscopy was used to image  
EGFP-VP40-K127A expressed in HEK293 cells elucidating VP40 enriched PM 
protrusions. (B) Brightness versus intensity plot displaying monomers and dimers (red box) 
and trimers and tetramers (blue box). Note that little to no hexamers are detected in the 
brightness versus intensity plot. (C) Brightness distribution of K127A at or on the PM 
displaying monomers or dimers (red) and trimers and tetramers (blue). (D) Frequency 
versus apparent brightness plot demonstrates significantly lower oligomerization of K127A 
(See Figure 5G also) at or near the PM of HEK293 cells. (E) TIRF intensity image 
displaying EGFP-VP40-K127A distribution at or near the PM (blue = least intense;  
red = most intense). VP40 oligomers are enriched in the cellular protrusions. (F) The 
cellular brightness map of EGFP-VP40-K127A from the TIRF image demonstrates the 
significant reduction in oligomerization compared to WT (blue = least intense; red = most 
intense). Scale bar = 18 µm. 
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Figure 7. N&B Analysis of N130A. (A) TIRF microscopy was used to image  
EGFP-VP40-N130A expressed in HEK293 cells elucidating a low level of N130A 
enriched PM protrusions. (B) Brightness versus intensity plot displaying monomers and 
dimers (red box) and trimers and tetramers (blue box). Note that little to no hexamers were 
detected in the brightness versus intensity plot. (C) Brightness distribution of N130A at or 
on the PM displaying monomers and dimers (red) or trimers and tetramers (blue). 
(D) Frequency versus apparent brightness plot demonstrates significantly lower 
oligomerization of N130A at or near the PM of HEK293 cells. (E) TIRF intensity image 
displaying EGFP-VP40-N130A distribution at or near the PM (blue = least intense;  
red = most intense). N130A enrichment at the PM and protrusion sites is greatly reduced 
compared to WT VP40 and even K127A (See Figure 5G). (F) Despite the presence of 
intense punctae of N130A at the PM, the cellular brightness map of EGFP-VP40-N130A 
from the TIRF image demonstrates the significant reduction in oligomerization or PM 
protrusions compared to WT and K127A (blue = least intense; red = most intense) (See 
Figure 5G). Scale bar = 18 µm. 
3.4. Viral Egress Studies 
To investigate the role of the N-terminal loop in VLP release we collected VLPs for each construct 
48 h post-transfection as described in the experimental procedures. The isolated VLPs and cell lysates 
were subjected to Western blot (Figure 8A) for the EGFP tag using blotting for GAPDH as a loading 
control. Western blot results demonstrated that mutation of any single residue in the N-terminal loop 
region harboring Lys127, Thr129 or Asn130 greatly reduced VLP release (Figure 8A). K86A and K90A, 
however, had similar release of VLPs to WT (Figure 8) in line with PM localization and 
oligomerization data. The VLP analysis was performed in triplicate and the density of VLP VP40, 
cytoplasmic VP40, and GAPDH loading control bands were quantified using Image J. These 
measurements were used to normalize signal to the GAPDH loading control and quantitatively 
demonstrate the reduction in VLP formation for K127A, T129A, and N130A (Figure 8B). Taken 
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together, the loop region harboring residues Lys127, Thr129 and Asn130 is important in VP40 PM 
localization, oligomerization and VLP release. 
 
 
Figure 8. VLP analysis of VP40 and respective mutations. CHOK-1 cells were transfected 
with plasmid DNA encoding either empty EGFP plasmid (control) or WT VP40, K86A, 
K90A, K127A, T129A, or N130A EGFP fusion constructs. (A) The cell lysate and VLPs 
were collected after 48 h as described previously [14,17,21] and subjected to Western blot 
with anti-EGFP. The ratio of cell lysate to VLPs was maintained for each sample with 
GAPDH used as a loading control for total cellular density. (B) Image J was used to 
quantify band density for each sample repeated in triplicate in order to determine the 
standard deviation. The band densities were first normalized to the GAPDH loading 
control and then normalized with respect to VP40 cell lysate band density. The normalized 
average band intensity is shown for cell lysate VP40 and VLP VP40 for each construct. 
4. Discussion 
In this study we have identified an important loop region in VP40 that is critical to effective PM 
localization, VP40 oligomerization, and VLP formation. This region, which resides in the N-terminal 
domain (See Figure 1A,B), is highly conserved among the five ebolaviruses identified to date. Lys127 
and Asn130 are invariably present among the five ebolaviruses (Bundibugyo virus, BDBV; Ebola virus, 
EBOV; Reston virus, RESTV; Sudan virus, SUDV; and Tai Forest virus, TAFV) while position 129 is 
a threonine in EBOV and a serine in the other four ebolaviruses. However, a threonine is also present 
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at position 128 in the BDBV and TAFV. Thr129 and Asn130 seem to be a bit more critical than Lys127 as 
mutation to alanine more dramatically reduced VLP formation. In contrast, mutation of cationic charge 
in the N-terminal domain as a whole (K86A and K90A) didn’t lead to nonspecific effects as these 
mutations localized analogous to WT and displayed robust VLP formation. Stability of loop region 
mutations doesn’t seem to be an issue as they expressed similar to WT, had overlapping CD spectra, 
and formation of perinuclear ring structures in cells was not observed which is associated with VP40 
octameric ring formation [13]. 
What exactly does this VP40 loop region interact with? At this juncture the molecular details are 
unknown but various protein or lipid interactions are possible. Interestingly, the loop region identified 
here is adjacent to and on the same interface as a CTD sequence (Lys212, Leu213, and Arg214) (See 
Figure 9) that was previously shown to be important for VP40 budding [28]. Mutation of this KLR 
sequence resulted in a drastic decrease in VLP release, reduced PM localization, and altered VP40 
oligomerization [28]. L213A was the most significant at knocking out budding [28] and TIRF studies 
indicated previously that L213A had a drastic reduction in PM binding and oligomerization in cells as 
well as membrane penetration in vitro [14]. Previous studies also have speculated that the region near 
Lys212 may form part of a weak interaction of the CTD and NTD, release of which may drive 
spontaneous oligomerization of VP40 [29]. For instance, C-terminal truncations of VP40 can lead to 
efficient hexamerization [16]. Reynard et al. also found that mutation of proline residues (Pro205, 
Pro211, and Pro215) in the CTD adjacent to the KLR sequence altered PM localization and budding of 
VLPs [29]. These mutations actually induced stronger binding to Sec24C and the author’s proposed 
that these mutations are not as efficient in dissociating from Sec24C, thus limiting their PM localization 
and egress [29]. In principle then, a similar effect could be proposed for the NTD loop region mutated 
here that lies adjacent to the C-terminal domain. However, in all cells for which we applied our cellular 
oligomerization analysis, the ability of VP40 to oligomerize was significantly inhibited suggesting 
again that defects in transport, membrane binding, protein-protein interactions, or oligomerization to 
VP40 filaments required for egress [13] are the most likely causes of the decrease in VLP formation. 
Additionally, we didn’t observe the enriched perinuclear structures of VP40 observed for VP40 
mutations that enhanced binding to Sec24C and altered transport [29]. Moreover, this loop is exposed 
in the VP40 octameric ring so mutations are not expected to inhibit ring formation or RNA binding. 
A number of cellular studies have elucidated important regions or residues in VP40 for cellular 
budding and egress to occur. For example, dimerization of VP40 is mediated by a NTD alpha-helix 
(Thr112 and Leu117) while hexamerization occurs through a CTD interface containing Ile307 and  
Met241 [13]. VP40 interacts with Sec24C through a hydrophobic patch in the C-terminal domain 
(residues 303–307), which is required for COPII vesicle transport [24]. The PTAP and PPxY late 
domains reside at the N-terminus of VP40 and are important for interactions with the ESCRT 
machinery and likely play a role in enhancing budding [30,33,34]. Pro283 and Pro286 have been shown 
to be important to VP40 localization to membrane rafts [25] while a sequence centered around Pro53 
may regulate an interaction with a novel host factor to achieve budding [35]. Similar to the 
aforementioned KLR sequence, the NTD sequence 96-LPLGVA-101 in EBOV and 84-LPLGIM-89 in 
MARV are also required for efficient budding [36].  
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Figure 9. The Lys127, Thr129, Asn130 N-terminal loop region is on the same interface as a  
C-terminal residue sequence previously identified to be important for VP40 budding. 
Lys127, Thr129, Asn130 (magenta) in the NTD (PDB ID: 4LDB) are adjacent and on the same 
interface as a CTD sequence (Lys212, Leu213, and Arg214 in cyan) previously shown to be 
important to VP40 PM localization and budding. 
Membrane binding is thought to occur through electrostatic interactions between the C-terminal 
domain (Lys224, 225, 274, and 275) and the anionic cytoplasmic PM leaflet [13]. Additionally, a 
hydrophobic loop region in the C-terminal domain (Ile293, Val295, and Leu298) selectively penetrates 
membranes that recapitulate the PM cytoplasmic leaflet but not the cytoplasmic leaflet of the nuclear 
membrane [14]. To the best of our knowledge and analysis, the loop region examined here (Lys127, 
Thr129, and Asn130) is distinct in terms of its role and may do something mechanistically different in 
egress than the interactions highlighted above. The recent and elegant structural information that has 
become available on VP40 [13] should allow researchers to better probe and understand VP40-host 
cell interactions including the loop region identified herein. 
The residues in this N-terminal loop aren’t strictly conserved in MARV VP40 but without structural 
information on MARV VP40 it is difficult to predict what these N-terminal domain loops may look 
like. This may suggest MARV and EBOV have differential means of lipid-protein or protein-protein 
interactions. This is in addition to possible differential mechanisms of intracellular trafficking of 
MARV and EBOV VP40, for which several recent studies have keenly elucidated some of the 
mechanisms of MARV VP40 intracellular trafficking [37]. Additionally, both EBOV VP40 and 
MARV VP40 have been shown to be Tyr phosphorylated in cells [38,39] so phosphorylation of Thr129 
(or Ser in other ebolaviruses) is something we cannot rule out at this time. 
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While a number of regions of VP40 that are key determinants of trafficking or release have been 
identified, much less mechanistic information is available on the molecular basis of VP40 interactions 
with human proteins or membrane lipids. Nonetheless, more detailed efforts are warranted to investigate 
the role of these amino acids in VP40 mediated assembly including investigation of interactions with 
other proteins, the PM, or COPII vesicle components. The loop region identified in this study in addition 
to several previous sequences revealed within the N- and C-terminal domains [28,29,36] should serve 
as a template to fully understand the transport, oligomerization, and budding of VP40 in human cells. 
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